Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02210857
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
PBS | (2S,3S,4R)-N-OCTANOYL-1-[(ALPHA- D-GALACTOPYRANOSYL)OXY]-2-AMINO- OCTADECANE-3,4-DIOL | A,C | 1Z5L | 0.71 | |
SIO | methyl 4,9-di-O-acetyl-5-(acetylamino)- 3,5-dideoxy-D-glycero-alpha-D-galacto- non-2-ulopyranosidonic acid | A | 3CL5 | 0.72 | |
AMV | METHYL 2-(ACETYLAMINO)-3-O-[(1R)- 1-CARBOXYETHYL]-2-DEOXY-BETA-D- GLUCOPYRANOSIDE | A | 2J8G | 0.74 | |
AMV | METHYL 2-(ACETYLAMINO)-3-O-[(1R)- 1-CARBOXYETHYL]-2-DEOXY-BETA-D- GLUCOPYRANOSIDE | A | 2J8F | 0.74 | |
MGU | 2-O-[2-O-METHYL-4-[2,4-DIHYDROXY- BUTYRAMIDO]-4,6-DIDEOXY-]-ALPHA- D-MANNOPYRANOSYL-[1-O-METHYL-4- [2,4-DIHYDROXY-BUTYRAMIDO]-4,6- DIDEOXY]-ALPHA-D-MANNOPYRANOSE | H | 1F4Y | 0.75 | |
SCM | SPECTINOMYCIN | A,D,H,N | 1FJG | 0.72 | |
SCM | SPECTINOMYCIN | A | 2QOY | 0.72 | |
SCM | SPECTINOMYCIN | A | 2QOU | 0.72 | |
SCM | SPECTINOMYCIN | A,E | 2QOW | 0.72 | |
SCM | SPECTINOMYCIN | A | 2QP0 | 0.72 | |
SKD | 2-ACETYLAMINO-7-(1,2-DIHYDROXY- ETHYL)-3-HYDROXY-6,8-DIOXA-BICYCLO[3.2.1]OCTANE- 5-CARBOXYLIC ACID | A | 2SLI | 0.72 | |
SKD | 2-ACETYLAMINO-7-(1,2-DIHYDROXY- ETHYL)-3-HYDROXY-6,8-DIOXA-BICYCLO[3.2.1]OCTANE- 5-CARBOXYLIC ACID | A | 2JKB | 0.72 | |
SKD | 2-ACETYLAMINO-7-(1,2-DIHYDROXY- ETHYL)-3-HYDROXY-6,8-DIOXA-BICYCLO[3.2.1]OCTANE- 5-CARBOXYLIC ACID | A | 3SLI | 0.72 | |
AH0 | 2-(2-ACETYLAMINO-4-HYDROXY-6,8- DIOXA-BICYCLO[3.2.1]OCT-3-YLOXY)- PROPIONIC ACID | A | 1QTE | 0.75 | |
MGS | 1,2-O-DIMETHYL-4-[2,4-DIHYDROXY- BUTYRAMIDO]-4,6-DIDEOXY-ALPHA-D- MANNOPYRANOSIDE | H | 1F4X | 0.75 | |
CNY | 13,15-DIAMINO-2-(AMINOMETHYL)-3,4,9,12- TETRAHYDROXYHEXADECAHYDRO-2H-7,10- EPOXYPYRANO[2,3-B][1,10,4]BENZODIOXAZACYCLODODECIN- 8-YL 2,6-DIAMINO-2,6-DIDEOXYHEXOPYRANOSIDE | A,C,D | 1ZZ5 | 0.7 | |
EAG | 2-aminoethyl 2-(acetylamino)-2- deoxy-beta-D-glucopyranoside | B,D,E,F,H | 3BZ4 | 0.71 | |
MLD | GLCNAC(BETA1-4)-MURNAC(1,6-ANHYDRO)- L-ALA-GAMMA-D-GLU-MESO-A2PM-D-ALA | A,X | 2F2L | 0.71 | |
MLD | GLCNAC(BETA1-4)-MURNAC(1,6-ANHYDRO)- L-ALA-GAMMA-D-GLU-MESO-A2PM-D-ALA | A,B,C,D | 2CB3 | 0.71 | |
ANA | 4-O-ACETYL-ALPHA-2-OMETHYL-5-N- ACETYL-ALPHA-D-NEURAMINIC ACID | A,B,C,D,E,F | 1HGI | 0.71 | |
AS5 | 2-(acetylamino)-4-O-[2-(acetylamino)- 2-deoxy-alpha-L-gulopyranosyl]- 1,5-anhydro-2-deoxy-D-mannitol | A,B | 2VLC | 0.72 | |
MUB | N-ACETYLMURAMIC ACID | L,N | 1WCO | 0.72 | |
GM2 | N-[(1S,2S)-2-HYDROXY-1-({[(2R,3R,4S,5S,6R)- 3,4,5-TRIHYDROXY-6-(HYDROXYMETHYL)TETRAHYDRO- 2H-PYRAN-2-YL]OXY}METHYL)OCTADECYL]OCTADECANAMIDE | A | 1GZP | 0.7 | |
CTO | TRIACETYLCHITOTRIOSE | A,B | 1BB5 | 0.72 | |
CTO | TRIACETYLCHITOTRIOSE | B | 2H5Z | 0.72 | |
CTO | TRIACETYLCHITOTRIOSE | A,B,C,D | 2R0H | 0.72 | |
CTO | TRIACETYLCHITOTRIOSE | A,B,C | 2AH9 | 0.72 | |
MGC | ALPHA-METHYL-N-ACETYL-D-GALACTOSAMINE | A,C,E,G | 1UH1 | 0.72 | |
MGC | ALPHA-METHYL-N-ACETYL-D-GALACTOSAMINE | A,B,C,D | 2DU1 | 0.72 | |
MGC | ALPHA-METHYL-N-ACETYL-D-GALACTOSAMINE | A,C,E,G | 1UH0 | 0.72 | |
MGC | ALPHA-METHYL-N-ACETYL-D-GALACTOSAMINE | A,B,C,D | 2DVA | 0.72 | |
MGC | ALPHA-METHYL-N-ACETYL-D-GALACTOSAMINE | A | 1UGX | 0.72 | |
FSM | FORSMANN ANTIGEN | A | 2CGY | 0.72 | |
MAG | BETA-METHYL-N-ACETYL-D-GLUCOSAMINE | A | 1M7D | 0.72 | |
MAG | BETA-METHYL-N-ACETYL-D-GLUCOSAMINE | A | 1LED | 0.72 | |
MAG | BETA-METHYL-N-ACETYL-D-GLUCOSAMINE | A | 1GSL | 0.72 | |
MAG | BETA-METHYL-N-ACETYL-D-GLUCOSAMINE | A | 1FWU | 0.72 | |
MAG | BETA-METHYL-N-ACETYL-D-GLUCOSAMINE | A,B,C,D | 1G1R | 0.72 | |
MAG | BETA-METHYL-N-ACETYL-D-GLUCOSAMINE | A | 1FWV | 0.72 | |
MAG | BETA-METHYL-N-ACETYL-D-GLUCOSAMINE | A | 1G1T | 0.72 | |
MAG | BETA-METHYL-N-ACETYL-D-GLUCOSAMINE | 1,2,3 | 3KMB | 0.72 | |
MAG | BETA-METHYL-N-ACETYL-D-GLUCOSAMINE | 1,2,3 | 2KMB | 0.72 | |
MAG | BETA-METHYL-N-ACETYL-D-GLUCOSAMINE | A,B | 1ZPL | 0.72 | |
MAG | BETA-METHYL-N-ACETYL-D-GLUCOSAMINE | 1,2,3 | 4KMB | 0.72 | |
MAG | BETA-METHYL-N-ACETYL-D-GLUCOSAMINE | A,H | 1UZ8 | 0.72 | |
AMU | BETA-N-ACETYLMURAMIC ACID | A,B,C,D | 2APH | 0.72 | |
AMU | BETA-N-ACETYLMURAMIC ACID | A,P | 1TWQ | 0.72 | |
AMU | BETA-N-ACETYLMURAMIC ACID | A | 1D0K | 0.72 | |
AMU | BETA-N-ACETYLMURAMIC ACID | S | 9LYZ | 0.72 | |
AMU | BETA-N-ACETYLMURAMIC ACID | E,S | 148L | 0.72 | |
AMU | BETA-N-ACETYLMURAMIC ACID | D,K | 3CYQ | 0.72 | |
AMU | BETA-N-ACETYLMURAMIC ACID | U | 2AIZ | 0.72 | |
B31 | (2S)-4-amino-N-[(1R,2S,3R,4R,5S)- 5-amino-4-[(2,6-diamino-2,6-dideoxy- alpha-D-glucopyranosyl)oxy]-2-hydroxy- 3-(beta-D-xylofuranosyloxy)cyclohexyl]- 2-hydroxybutanamide | A | 3H8P | 0.79 | |
AKN | (2R)-4-AMINO-N-{(1R,2S,3S,4R,5S)- 5-AMINO-2-[(3-AMINO-3-DEOXY-ALPHA- D-GLUCOPYRANOSYL)OXY]-4-[(6-AMINO- 6-DEOXY-ALPHA-D-GLUCOPYRANOSYL)OXY]- 3-HYDROXYCYCLOHEXYL}-2-HYDROXYBUTANAMIDE | A,B | 2G5Q | 0.77 | |
GTH | 3-O-GLUCOPYRANOSYL-THREONINE-[2- DEOXY-2-ACETAMIDO-GLUCOPYRANOSIDE] | A | 1WCT | 0.74 | |
GM3 | N-{1-[(HEXOPYRANOSYLOXY)METHYL]- 2-HYDROXYNONADECYL}TETRACOSANAMIDE | A | 2BV7 | 0.7 | |
TNR | O-(2-ACETAMIDO-2-DEOXY-ALPHA-D- GALACTOPYRANOSYL)-L-SERINE | A,B,C,D | 1N47 | 0.71 | |
TNR | O-(2-ACETAMIDO-2-DEOXY-ALPHA-D- GALACTOPYRANOSYL)-L-SERINE | A | 2CGZ | 0.71 | |
TNR | O-(2-ACETAMIDO-2-DEOXY-ALPHA-D- GALACTOPYRANOSYL)-L-SERINE | A,B,C,D | 2D3S | 0.71 | |
TNR | O-(2-ACETAMIDO-2-DEOXY-ALPHA-D- GALACTOPYRANOSYL)-L-SERINE | A | 2D7R | 0.71 | |
XIL | 3-HYDROXY-4-(3,4,5-TRIHYDROXY-TETRAHYDRO- PYRAN-2-YLOXY)-PIPERIDIN-2-ONE | A | 1J01 | 0.75 | |
AB9 | (2R)-4-AMINO-N-{(1R,2S,3R,4R,5S)- 5-AMINO-2-{2-[(2-AMINOETHYL)AMINO]ETHOXY}- 4-[(2,6-DIAMINO-2,6-DIDEOXY-ALPHA- D-GLUCOPYRANOSYL)OXY]-3-HYDROXYCYCLOHEXYL}- 2-HYDROXYBUTANAMIDE | A,D,M,N,Z | 2F4V | 0.75 | |
AB9 | (2R)-4-AMINO-N-{(1R,2S,3R,4R,5S)- 5-AMINO-2-{2-[(2-AMINOETHYL)AMINO]ETHOXY}- 4-[(2,6-DIAMINO-2,6-DIDEOXY-ALPHA- D-GLUCOPYRANOSYL)OXY]-3-HYDROXYCYCLOHEXYL}- 2-HYDROXYBUTANAMIDE | B | 2F4T | 0.75 | |
SLT | 5-(ACETYLAMINO)-3,5-DIDEOXYNON- 2-ULOPYRANONOSYL-(2->3)-BETA-D- LYXO-HEXOPYRANOSYL-(1->4)HEXOPYRANOSE | A | 1S0I | 0.75 | |
SLT | 5-(ACETYLAMINO)-3,5-DIDEOXYNON- 2-ULOPYRANONOSYL-(2->3)-BETA-D- LYXO-HEXOPYRANOSYL-(1->4)HEXOPYRANOSE | A | 1Z4X | 0.75 | |
AMN | 9-DEOXY-9-AMINO-2-O-METHYL-5-N- ACETYL-ALPHA-D-NEURAMINIC ACID | A,B,C,D,E,F | 1HGJ | 0.71 | |
GSL | (2S,3R)-3-HYDROXY-2-(TETRADECANOYLAMINO)OCTADECYL ALPHA- D-GALACTOPYRANOSIDURONIC ACID | A | 2FIK | 0.76 | |
5DP | 5-(2,5-dioxopyrrolidin-1-yl)-N- [2-(2-{2-[(4-O-alpha-D-idopyranosyl- alpha-D-mannopyranosyl)oxy]ethoxy}ethoxy)ethyl]pentanamide | A,B,C,D | 3CIU | 0.72 | |
BGN | N-BUTANOYL-2-AMINO-2-DEOXY-GLUCOPYRANOSIDE | A,B,C,D | 1NWG | 0.72 | |
AB6 | (2R)-4-AMINO-N-((1R,2S,3R,4R,5S)- 5-AMINO-4-[(2-AMINO-2-DEOXY-ALPHA- D-GLUCOPYRANOSYL)OXY]-2-{2-[(3- AMINOPROPYL)AMINO]ETHOXY}-3-HYDROXYCYCLOHEXYL)- 2-HYDROXYBUTANAMIDE | B | 2F4U | 0.77 | |
MMR | N-((2R,3R,4S,6S)-6-(HYDROXYMETHYL)- 2-METHOXY-4-((S)-1-OXOPROPAN-2- YLOXY)TETRAHYDRO-2H-PYRAN-3-YL)ETHANAMIDE | L | 2EAX | 0.73 | |
NLC | 2-(ACETYLAMINO)-2-DEOXY-4-O-BETA- D-GALACTOPYRANOSYL-ALPHA-D-GLUCOPYRANOSE | A,B | 2VS4 | 0.71 | |
NLC | 2-(ACETYLAMINO)-2-DEOXY-4-O-BETA- D-GALACTOPYRANOSYL-ALPHA-D-GLUCOPYRANOSE | A | 1W3G | 0.71 | |
NLC | 2-(ACETYLAMINO)-2-DEOXY-4-O-BETA- D-GALACTOPYRANOSYL-ALPHA-D-GLUCOPYRANOSE | A,B | 3EHN | 0.71 | |
NLC | 2-(ACETYLAMINO)-2-DEOXY-4-O-BETA- D-GALACTOPYRANOSYL-ALPHA-D-GLUCOPYRANOSE | A | 1W3F | 0.71 | |
NLC | 2-(ACETYLAMINO)-2-DEOXY-4-O-BETA- D-GALACTOPYRANOSYL-ALPHA-D-GLUCOPYRANOSE | A | 1ZJ1 | 0.71 | |
NLC | 2-(ACETYLAMINO)-2-DEOXY-4-O-BETA- D-GALACTOPYRANOSYL-ALPHA-D-GLUCOPYRANOSE | A | 2YY1 | 0.71 | |
NLC | 2-(ACETYLAMINO)-2-DEOXY-4-O-BETA- D-GALACTOPYRANOSYL-ALPHA-D-GLUCOPYRANOSE | A | 1ZI3 | 0.71 | |
NLC | 2-(ACETYLAMINO)-2-DEOXY-4-O-BETA- D-GALACTOPYRANOSYL-ALPHA-D-GLUCOPYRANOSE | A,B | 2VS3 | 0.71 | |
MU2 | N-ACETYLMURAMYL-L-ALANYL-D-ISOGLUTAMINE | A | 2IXV | 0.7 | |
MU2 | N-ACETYLMURAMYL-L-ALANYL-D-ISOGLUTAMINE | A | 2IXU | 0.7 | |
MNA | 2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID | A | 2P3I | 0.71 | |
MNA | 2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID | A | 1KQR | 0.71 | |
MNA | 2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID | A,B,C,D,E,F | 1HGH | 0.71 | |
MNA | 2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID | A,B | 2I2S | 0.71 | |
MNA | 2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID | A | 2P3J | 0.71 | |
MNA | 2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID | A,B,C,D,E,F | 1HGE | 0.71 | |
MNA | 2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID | A | 2P3K | 0.71 | |
AGH | N-{(1S,2R,3S)-1-[(ALPHA-D-GALACTOPYRANOSYLOXY)METHYL]- 2,3-DIHYDROXYHEPTADECYL}HEXACOSANAMIDE | A | 1ZT4 | 0.71 | |
AGH | N-{(1S,2R,3S)-1-[(ALPHA-D-GALACTOPYRANOSYLOXY)METHYL]- 2,3-DIHYDROXYHEPTADECYL}HEXACOSANAMIDE | A,C,E | 2PO6 | 0.71 | |
NGC | 3,5-dideoxy-5-[(hydroxyacetyl)amino]- D-glycero-alpha-D-galacto-non-2- ulopyranosonic acid | A,B,C,D,E | 3DWP | 0.7 | |
NGC | 3,5-dideoxy-5-[(hydroxyacetyl)amino]- D-glycero-alpha-D-galacto-non-2- ulopyranosonic acid | A,B,C,D,E | 3DWQ | 0.7 | |
CBS | DI(N-ACETYL-D-GLUCOSAMINE) | A | 1LJN | 0.72 | |
CBS | DI(N-ACETYL-D-GLUCOSAMINE) | A | 1ZU0 | 0.72 | |
CBS | DI(N-ACETYL-D-GLUCOSAMINE) | A | 2HRH | 0.72 | |
CBS | DI(N-ACETYL-D-GLUCOSAMINE) | A,B | 1TW5 | 0.72 | |
CBS | DI(N-ACETYL-D-GLUCOSAMINE) | A,H | 2HRG | 0.72 | |
CBS | DI(N-ACETYL-D-GLUCOSAMINE) | 1 | 2BS7 | 0.72 | |
CBS | DI(N-ACETYL-D-GLUCOSAMINE) | A | 1C7T | 0.72 | |
CBS | DI(N-ACETYL-D-GLUCOSAMINE) | A,B | 2QT6 | 0.72 | |
CBS | DI(N-ACETYL-D-GLUCOSAMINE) | A | 1QBB | 0.72 | |
CBS | DI(N-ACETYL-D-GLUCOSAMINE) | A | 1C7S | 0.72 | |
DR2 | 6-DEOXY-ALPHA-L-IDOPYRANOSYL-(1- >2)-ALPHA-D-GLUCOPYRANOSYL-(1->4)- 2-(ACETYLAMINO)-2-DEOXY-BETA-L- GULOPYRANOSE | A | 3E6J | 0.74 | |
DR2 | 6-DEOXY-ALPHA-L-IDOPYRANOSYL-(1- >2)-ALPHA-D-GLUCOPYRANOSYL-(1->4)- 2-(ACETYLAMINO)-2-DEOXY-BETA-L- GULOPYRANOSE | A | 1ZJ3 | 0.74 | |
DR2 | 6-DEOXY-ALPHA-L-IDOPYRANOSYL-(1- >2)-ALPHA-D-GLUCOPYRANOSYL-(1->4)- 2-(ACETYLAMINO)-2-DEOXY-BETA-L- GULOPYRANOSE | A | 1ZI4 | 0.74 |